Mark D. Cohoon, PA-C

Mark Cohoon practices at Premier Valley Medical Group in Bakersfield, California.

Mark Cohoon's NPI, 1497754089, was assigned on July 18, 2005. Mark Cohoon holds California license 15156.

Mark Cohoon's primary practice is Premier Valley Medical Group, at 5401 White Ln, Bakersfield, CA 93309-6279. The practice phone is (661) 396-7100.

Mark Cohoon's primary practice is Premier Valley Medical Group in Bakersfield, California. The medical group on file is Premier Valley Medical Group. Dmand AI also links Mark Cohoon to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Cohoon practices. Vendor and product names are available with a free account.

Physician assistant is Mark Cohoon's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Mark Cohoon is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Mark Cohoon is licensed in California.

Dmand AI lists acute sinusitis, acute skin infection, alzheimer's disease, arthritis, asthma, bursitis, chronic kidney disease and depression among the conditions Mark Cohoon treats.

CMS data shows 274 Medicare services from Mark Cohoon across 4 procedure codes in 2024, for 52 Medicare patients. Medicare paid $23,310 for them. Every service was in an office.

CMS counts 52 Medicare patients who saw Mark Cohoon in 2024. The largest group is 65 to 74, with 26 patients. 50% of them have high blood pressure, and 48% have anxiety. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Cohoon's median patient age at 50, with 36% women.

In 2024, Mark Cohoon wrote 848 Medicare Part D claims for 227 patients. 89% of them were for generic drugs. CMS names the drug for 460 of them, across 20 drugs with 11 or more claims each, at $22,137 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Mark Cohoon for performance year 2024, reported as part of a group. Mark Cohoon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mark Cohoon as offering telehealth.

CMS Open Payments shows 27 general payments to Mark Cohoon from 8 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $476.